The role of focal infections in the pathogenesis of psoriasis and chronic urticaria

Postepy Dermatologii i Alergologii

Volumn 30, Issue 2, 2013, Pages 77-84

  Brzewski, Paweł Łukasz ^a   Spałkowska, Magdalena ^a   Podbielska, Magdalena ^a   Chmielewska, Joanna ^a   Wołek, Marta ^a   Malec, Katarzyna ^b   Wojas Pelc, Anna ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b Military Clinical Hospital Krakow   (Poland)

Author keywords

Focal infection; Psoriasis; Urticaria

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC URTICARIA; CONSULTATION; DENTAL CARIES; FEMALE; HUMAN; INCIDENCE; INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PATHOGENESIS; PSORIASIS; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; PSORIATIC ERYTHRODERMA; PUSTULAR PSORIASIS; RETROSPECTIVE STUDY; SINUSITIS; TONSILLITIS; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION;

EID: 84878431547     PISSN: 1642395X     EISSN: None     Source Type: Journal    
DOI: 10.5114/pdia.2013.34155     Document Type: Article

References (68)

1. Sheikh J. Autoantibodies to the high-affinity IgE receptor in chronic urticaria: how important are they? Curr Opin Allergy Clin Immunol 2005; 5: 403-7.
2. Kulthanan K, Jiamton S, Thumpimukvatana N, Pinkaew S. Chronic idiopathic urticaria: prevalence and clinical course. J Dermatol 2007; 34: 294-301.
3. Spiewak R. The substantial differences between photoallergic and phototoxic reactions. Ann Agric Environ Med 2012; 19: 888-9.
4. Osmola-Mankowska A, Silny W, Danczak-Pazdrowska A, et al. The sun - our friend or foe? Ann Agric Environ Med 2012; 19: 805-9.
5. Krupa Shankar DS, Ramnane M, Rajouria EA. Etiological approach to chronic urticaria. Indian J Dermatol 2010; 55: 33-8.
6. Sabroe RA, Grattan CE, Francis DM, et al. The autologous serum skin test: screening test for auto antibodies in chronic idiopathic urticaria. Br J Dermatol 1999; 140: 446-52.
7. Zukiewicz-Sobczak W, Krasowska E, Zwolinski J, et al. Allergic diseases - current state of knowledge. Postep Derm Alergol 2012; 29: 451-5.
8. Najib U, Bajwa ZH, Ostro MG, Sheikh J. A retrospective review of clinical presentation, thyroid autoimmunity, laboratory characteristics, and therapies used in patients with chronic idiopathic urticaria. Ann Allergy Asthma Immunol 2009; 103: 496-501.
9. Kanani A, Schellenberg R, Warrington R. Urticaria and angioedema. Allergy Asthma Clin Immunol 2011; 7 (Suppl 1): S9.
10. Jirapongsananuruk O, Pongpreuksa S, Sangacharoenkit P, et al. Identification of the etiologies of chronic urticaria in children: a prospective study of 94 patients. Pediatr Allergy Immunol 2010; 21: 508-14.
11. Yang HY, Sun CC, Wu YC, Wang JD. Stress, insomnia, and chronic idiopathic urticaria: a case-control study. J Formos Med Assoc 2005; 104: 254-63.
12. Confino-Cohen R, Chodick G, Shalev V, et al. Chronic urticaria and autoimmunity: associations found in a large population study. J Allergy Clin Immunol 2012; 129: 1307-13.
13. Kaplan AP, Finn A. Autoimmunity and the etiology of chronic urticaria. Can J Allergy Clin Immunol 1999; 4: 286-92.
14. Kikuchi Y, Fann T, Kaplan AP. Antithyroid antibodies in chronic urticaria and angioedema. J Allergy Clin Immunol 2003; 112: 218.
15. Dreskin SC, Andrews KY. The thyroid and urticaria. Curr Opin Allergy Clin Immunol 2005; 5: 408-12.
16. Brodell LA, Beck LA. Differential diagnosis of chronic urticaria. Ann Allergy Asthma Immunol 2008; 100: 181-8.
17. Buss YA, Garrelfs UC, Sticherling M. Chronic urticaria which clinical parameters are pathogenetically relevant? A retrospective investigation of patients. J Dtsch Dermatol Ges 2007; 5: 22-9.
18. Asero R, Tedeschi A, Riboldi P, Cugno M. Plasma of patients with chronic urticaria shows signs of thrombin generation, and its intradermal injection causes wheal-and-flare reactions much more frequently than autologous serum. J Allergy Clin Immunol 2006; 117: 1113-7.
19. Asero R, Tedeschi A, Coppola R, et al. Activation of the tissue factor pathway of blood coagulation in patients with chronic urticaria. J Allergy Clin Immunol 2007; 119: 705-10.
20. Takahagi S, Mihara S, Iwamoto K, et al. Coagulation/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticaria. Allergy 2010; 65: 649-56.
21. Horn MP, Pachlopnik JM, Vogel M, et al. Conditional autoimmunity mediated by human natural anti-Fc(epsilon)RIalpha autoantibodies? FASEB J 2001; 15: 2268-74.
22. Vasagar K, Vonakis BM, Gober LM, et al. Evidence of in vivo basophil activation in chronic idiopathic urticaria. Clin Exp Allergy 2006; 36: 770-6.
23. Jacques P, Lavoie A, Bédard PM, et al. Chronic idiopathic urticaria: profiles of skin mast cell histamine release during active disease and remission. J Allergy Clin Immunol 1992; 89: 1139-43.
24. Nevitt GJ, Hutchinson PE Psoriasis in the community: prevalence, severity and patients' beliefs and attitudes towards the disease. Br J Dermatol 1996; 135: 533-7.
25. Gelfand JM, Stern RS, Nijsten T, et al. The prevalence of psoriasis in African Americans: results from a population-based study. J Am Acad Dermatol 2005; 52: 23-6.
26. Rapp SR, Feldman SR, Exum ML, et al. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999; 41: 401-24.
27. Gudjonsson JE, Thorarinsson AM, Sigurgeirsson B, et al. Streptococcal throat infections and exacerbation of chronic plaque psoriasis: a prospective study. Br J Dermatol 2003; 149: 530-4.
28. Fortes C, Mastroeni S, Leffondré K, et al. Relationship between smoking and the clinical severity of psoriasis. Arch Dermatol 2005; 141: 1580-4.
29. Rasmy H, Mikhael N, Ismail S. Interleukin-18 expression and the response to treatment in patients with psoriasis. Arch Med Sci 2011; 7: 713-9.
30. Huerta C, Rivero E, Rodríguez LA. Incidence and risk factors for psoriasis in the general population. Arch Dermatol 2007; 143: 1559-65.
31. Herron MD, Hinckley M, Hoffman MS, et al. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol 2005; 141: 1527-34.
32. Balato N, Di Costanzo L, Balato A. Differential diagnosis of psoriasis. J Rheumatol Suppl 2009; 83: 24-5.
33. Krueger JG, Bowcock A. Psoriasis pathophysiology: current concepts of pathogenesis. Ann Rheum Dis 2005; 64 (Suppl II): ii30-6.
34. Rajeev Das, Arun Jain, V Ramesh V. Current concepts in the pathogenesis of psoriasis. Indian J Dermatol 2009; 54: 1, 7-12.
35. Cepicka W, Tielsch R. Focal infections and psoriasis vulgaris. Dermatol Wochenschr 1967; 153: 193-9.
36. Blok S, Vissers WH, Van Duinhoven M, Van de Kerkhof PC. Aggravation of psoriasis by infections: a constitutional trait or a variable expression? Eur J Dermatol 2004; 14: 259-61.
37. Nomura K, Mizutani H, Inachi S, Shimizu M. Remission of pustular psoriasis after cholecystectomy: role of focal infection in pustularization of psoriasis. J Dermatol 1995; 22: 122-4.
38. Mizutani H, Ohmoto Y, Mizutani T, et al. Role of increased production of monocytes TNF-alpha, IL-1beta and IL-6 in psoriasis: relation to focal infection, disease activity and responses to treatments. Dermatol Sci 1997; 14: 145-53.
39. Yamamoto T. Triggering role of focal infection in the induction of extra-palmoplantar lesions and pustulotic arthroosteitis associated with palmoplantar pustulosis. Adv Otorhinolaryngol 2011; 72: 89-92.
40. Krstić A, Zivković M, Janjatović T. Significance of focal infection in psoriasis vulgaris and psoriasis arthropathica. Hautarzt 1969; 20: 274-6.
41. Fujihara K. A study on the tonsil with focal infections-with special reference to the newly devised tonsillar cryptscope and the architecture of vessels in crypts. Nihon Jibiinkoka Gakkai Kaiho 1991; 94: 1304-14.
42. Ruszczak Z, Bednarowicz G, Prószynska-Kuczynska W. The role of focal infection in the etiopathogenesis of psoriasis. Przegl Dermatol 1969; 56: 15-20.
43. Fry L, Baker BS. Triggering psoriasis: the role of infections and medications. Clin Dermatol 2007; 25: 606-15.
44. Francke OC. William Hunter's "oral sepsis" as a cause of disease. Periodontology 2000; 23: 13-8.
45. Miller WD. The micro-organisms of the human mouth: the local and general diseases which are caused by them.S.S. White, Philadelphia 1880.
46. Miller WD. The human mouth as a focus of infection. Dent Cosmos 1891; 33: 689-713.
47. Billings F. Chronic focal infections and their etiologic rel ations to arthritis and nephritis. Arch Int Med 1912; 9: 484-98.
48. Billings F. Focal infection: the lane medical lectures. D. Appleton and Company, New York 1916.
49. Ercolini AM, Miller SD. The role of infections in autoimmune disease. Clin Exp Immunol 2009; 155: 1-15.
50. Boguniewicz M. The autoimmune nature of chronic urticaria. Allergy Asthma Proc 2008; 29: 433-8.
51. Greaves MW, Tan KT. Chronic urticaria: recent advances. Clin Rev Allergy Immunol 2007; 33: 134-43.
52. Coban M, Erdem T, Ozdemir S, et al. HLA class I and class II genotyping in patients with chronic urticaria. Int Arch Allergy Immunol 2008; 147: 135-9.
53. O'Donell BF, O'Neill CM, Francis DM, et al. Human leukocyte antigen class II associations in chronic idiopathic urticaria. Br J Dermatol 1999; 140: 853-8.
54. Aydogan K, Karadogan SK, Akdag I, Tunali S. HLA class I and class II antigens in Turkish patients with chronic ordinary urticaria. Clin Exp Dermatol 2006; 31: 424-9.
55. Wedi B, Novacovic V, Koerner M, Kapp A. Chronic urticaria serum induces histamine release, leukotriene production, and basophil CD63 surface expression: inhibitory effects of anti-inflammatory drugs. J Allergy Clin Immunol 2000; 105: 552-60.
56. Wedi B, Raap U, Kapp A. Chronic urticaria and infections. Curr Opin Allergy Clin Immunol 2004; 4: 387-96.
57. Wedi B, Liekenbröcker T, Kapp A. Persistent bacterial infections and serum acitivity in chronic urticaria - role of molecular mimicry? Allergologie 2001; 24: 480-90.
58. Bakos N, Hillander M. Comparison of chronic autoimmune urticaria with chronic idiopathic urticaria. Int J Dermatol 2003; 42: 613-5.
59. Wedi B, Raap U, Wieczorek D, Kapp A. Urticaria and infections. Allergy Asthma Clin Immunol 2009; 5: 10.
60. Wedi B. Urticaria. J Deutsch Dermatol Ges 2008; 6: 306-17.
61. Leiste A, Skaletz-Rorowski A, Venten I, et al. Urticaria associated with Norovirus infection: report of two cases. J Dtsch Dermatol Ges 2008; 6: 563-23.
62. Trachsel C, Pichler WJ, Helbling A. Importance of laboratory investigations and trigger factors in chronic urticaria. Schweiz Med Wochenschr 1999; 129: 1271-9.
63. Giacometti A, Cirioni O, Antonicelli L, et al. Prevalence of intestinal parasites among individuals with allergic skin diseases. J Parasitol 2003; 89: 490-2.
64. Ronellenfitsch U, Bircher A, Hatz C, Blum J. Parasites as a cause of urticaria. Helminths and protozoa as triggers of hives? Hautarzt 2007; 58: 133-4, 136-41.
65. Wedi B, Kapp A. Urticaria and angioedema. In: Allergy: practical diagnosis and management. Mahmoudi M (ed.). Mc - Graw Hill, New York 2008; 84-94.
66. Buss YA, Garrelfs UC, Sticherling M. Chronic urticaria: which clinical parameters are pathogenetically relevant? A retrospective investigation of 339 patients. J Dtsch Dermatol Ges 2007; 5: 22-7.
67. Goga D, Vaillant L, Pandraud L, et al. The elimination of dental and sinusal infectious foci in dermatologic pathology. A double-blind study in 27 cases confined to chronic urticaria. Rev Stomatol Chir Maxillofac 1988; 89: 273-5.
68. Buchter A, Kruse-Losler B, Joos U, Kleinheinz J. Odontogenic foci: possible etiology of urticaria? Mund Kiefer Gesichtschir 2003; 7: 335-8.